CROI 2024 Report Back: Treatment Updates

Sdílet
Vložit
  • čas přidán 14. 04. 2024
  • Dr. Jehan Budak summarizes key study results from the CROI 2024 conference that focus on antiretroviral treatment, especially long-acting injectable cabotegravir/rilpivirine and lenacapavir.

Komentáře •